Some studies reported that patients with NAFLD had lower adiponectin concentration compared with the others and adiponectin can be considered as a predictor of the severity of hepatic steatosis (Targher et al., 2006; Nakano et al., 2011). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.